RESEARCH-USE BIOSIMILAR ANTIBODY
Crotedumab
Monoclonal antibody · IgG4
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes.
TARGETGCGR
YMonoclonal antibody
CATALOGSC-BS-652
CATALOG NUMBERSC-BS-652
MOLECULAR WEIGHTApprox. 146.82 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes.
Crotedumab is a recombinant research-use antibody directed against GCGR.